Delivery Order 75N93018D00007-75N93020F00003
Award Date 6/10/20
Potential Completion Date 8/28/20
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Charles, MO, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a $1,095,062 delivery order to Eurofins Discovery Services North America, LLC on February 25, 2026, for interventional agents safety and pharmacokinetic services, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ vehicle. Place of performance is St. Charles, Missouri. The order carries a firm fixed price structure and ultimate completion date of February 24, 2027. No set-aside was used.
- The National Institute of Allergy and Infectious Diseases issued a $75,000 delivery order to Eurofins Discovery Services North America, LLC on July 16, 2019, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ for non-GLP off-the-shelf standard initial profiling of lead compounds in rodent pharmacokinetics screening assays. The order has a ceiling value of $112,500 and an ultimate completion date of July 17, 2020. Place of performance is St. Charles, MO....
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Eurofins Discoverx LLC for $32,932.40 on April 1, 2021, for G-protein coupled receptor (GPCR) screening under a Coronavirus COVID-19 national interest action. Performance is at Fremont, California. The order has a firm fixed price and completed on May 1, 2021.</p>
- This delivery order, awarded May 1, 2018, provides nonclinical services for the development of interventional agents targeting infectious diseases through the National Institute of Allergy and Infectious Diseases (NIAID). Eurofins Discovery Services North America, LLC, a foreign-owned contract research organization headquartered in St. Charles, Missouri, was awarded this firm-fixed-price delivery order with a ceiling value of $1.21 million and an ultimate completion date of April 30, 2025. The...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on April 1, 2020, with a ceiling value of $8.95 million for nonclinical services supporting the development of interventional agents for infectious diseases. The order is issued under the Nonclinical Services for Development of Interventional Agents parent IDIQ. Work is performed in Menlo Park, CA, with an ultimate completion date of March 31, 2021. The contract is priced on a...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Curia Global Inc. on March 22, 2019, under the Nonclinical Services for Development of Interventional Agents IDIQ for non-clinical services in development of interventional agents for infectious diseases, with a ceiling value of $542,766. Place of performance is Albany, NY. The order has an ultimate completion date of March 21, 2020. Work is performed on a cost-plus-fixed-fee basis with no set-aside applied.
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Eurofins Genomics LLC on May 6, 2015, with a ceiling value of $9,683.97 for oligonucleotides. Performance is located in Huntsville, Alabama. The order is firm fixed price with no set-aside designation. Ultimate completion is September 30, 2015.</p>
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Medical Science & Computing, LLC on April 1, 2019, with a ceiling value of $42,143.19 for professional, scientific, and technical support services to the Division of Intramural Research. Place of performance is Germantown, MD. The order is firm fixed price with an ultimate completion date of September 28, 2020. This delivery order was issued to administratively de-obligate unexpended and expiring fiscal year...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $464,720.00 firm fixed price delivery order contract to Eurofins Panlabs, Inc. for nonclinical services to support the development of interventional agents for infectious diseases. The contract is associated with a larger indefinite delivery/indefinite quantity (IDIQ) vehicle titled "Nonclinical Services for Development of Interventional Agents."...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to The Geneva Foundation on January 11, 2019, with a ceiling value of $142,614.09 under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite delivery vehicle for in vitro assessments of antimicrobial activity. The order requires determination of antiviral inhibitory effects and cytotoxicity of experimental antiviral compounds against viruses, including rapidly emerging viruses utilizing the same...